News

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug
Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's ...
The Manila Times6h
IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel
SHANGHAI, NANJING, China and SAN FRANCISCO, July 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ('IASO Bio'), a biopharmaceutical company focused on the discovery, development, manufacturing, and ...
MediaNama11h
FSSAI: E-Commerce Platforms Could Face Severe Action Over Food Safety Non-Compliance
FSSAI warns e-commerce platforms to comply with food safety rules or face action, citing violations in dark stores and poor ...
Outlook Business6h
FSSAI Warns Ecommerce Platforms Over Food Safety Violations: 'Follow Norms or Face Action'
With the rise of online food sales, FSSAI has tightened the screws on digital marketplaces, reminding them of their legal obligations. The authority emphasized full visibility of licensing info and gr ...
Merck nears $10bn deal for respiratory drugmaker Verona
US pharma giant seeks to expand footprint beyond cancer treatment as its biggest product nears patent cliff ...
Pharmabiz16h
Safety in pharma manufacturing discussed at CII Telangana “Pillars of Protection” conference in Hyderabad
Safety in pharma manufacturing discussed at CII Telangana “Pillars of Protection” conference in Hyderabad: Shardul Nautiyal, Mumbai Wednesday, July 9, 2025, 08:00 Hrs [IST] Sa ...
Bispecifics/Bite Market Anticipates Impressive Growth Trajectory During The Forecast Period (2025-2034) Across 7MM Due To Their Expansion Beyond Oncology Delveinsight
The bispecific antibody and BiTE market is witnessing robust growth driven by advances in immuno-oncology and rising demand for targeted canc ...